NDRG1
Basic information
Region (hg38): 8:133237175-133302022
Previous symbols: [ "CAP43" ]
Links
Phenotypes
GenCC
Source:
- Charcot-Marie-Tooth disease type 4D (Supportive), mode of inheritance: AR
- Charcot-Marie-Tooth disease type 4D (Strong), mode of inheritance: AR
- Charcot-Marie-Tooth disease type 4D (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Charcot-Marie-Tooth disease, type 4D | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Musculoskeletal; Neurologic | 10831399; 22978647; 23163601; 24136616 |
ClinVar
This is a list of variants' phenotypes submitted to
- Charcot-Marie-Tooth disease type 4 (14 variants)
- Charcot-Marie-Tooth disease type 4D (5 variants)
- not provided (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NDRG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 181 | 182 | ||||
missense | 196 | 196 | ||||
nonsense | 11 | |||||
start loss | 2 | |||||
frameshift | 8 | |||||
inframe indel | 10 | 11 | ||||
splice donor/acceptor (+/-2bp) | 16 | 20 | ||||
splice region | 16 | 49 | 4 | 69 | ||
non coding | 34 | 159 | 67 | 261 | ||
Total | 18 | 18 | 244 | 343 | 68 |
Highest pathogenic variant AF is 0.00000657
Variants in NDRG1
This is a list of pathogenic ClinVar variants found in the NDRG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-133237256-A-C | Charcot-Marie-Tooth disease type 4D | Likely benign (Apr 27, 2017) | ||
8-133237257-G-A | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 12, 2018) | ||
8-133237405-C-T | Charcot-Marie-Tooth disease type 4D | Likely benign (Jan 12, 2018) | ||
8-133237517-G-T | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Apr 20, 2018) | ||
8-133237538-C-T | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 13, 2018) | ||
8-133237539-G-A | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 12, 2018) | ||
8-133237578-C-G | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 13, 2018) | ||
8-133237579-G-A | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 12, 2018) | ||
8-133237582-G-A | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 13, 2018) | ||
8-133237584-A-G | Charcot-Marie-Tooth disease type 4D | Benign (Jan 12, 2018) | ||
8-133237683-C-A | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 12, 2018) | ||
8-133237699-C-G | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 12, 2018) | ||
8-133237743-C-T | Charcot-Marie-Tooth disease type 4D | Benign (Jan 13, 2018) | ||
8-133237922-A-G | Charcot-Marie-Tooth disease type 4D | Benign (Jan 13, 2018) | ||
8-133238012-T-A | Charcot-Marie-Tooth disease type 4D | Benign (Jan 12, 2018) | ||
8-133238024-C-T | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 13, 2018) | ||
8-133238044-A-T | Charcot-Marie-Tooth disease type 4D | Benign (Jan 13, 2018) | ||
8-133238087-G-A | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 13, 2018) | ||
8-133238167-G-A | Charcot-Marie-Tooth disease type 4D | Benign (Jan 13, 2018) | ||
8-133238187-C-T | Charcot-Marie-Tooth disease type 4D | Benign (Jan 13, 2018) | ||
8-133238201-G-A | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 13, 2018) | ||
8-133238225-A-G | Charcot-Marie-Tooth disease type 4D | Likely benign (Apr 27, 2017) | ||
8-133238260-A-C | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 12, 2018) | ||
8-133238353-C-T | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 13, 2018) | ||
8-133238475-C-T | Charcot-Marie-Tooth disease type 4D | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NDRG1 | protein_coding | protein_coding | ENST00000414097 | 15 | 64852 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0113 | 0.988 | 125718 | 1 | 29 | 125748 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.651 | 226 | 255 | 0.885 | 0.0000168 | 2579 |
Missense in Polyphen | 88 | 109.67 | 0.80238 | 1081 | ||
Synonymous | -0.664 | 110 | 101 | 1.08 | 0.00000744 | 763 |
Loss of Function | 3.14 | 8 | 24.9 | 0.322 | 0.00000127 | 271 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000787 | 0.000647 |
European (Non-Finnish) | 0.0000967 | 0.0000791 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Stress-responsive protein involved in hormone responses, cell growth, and differentiation. Acts as a tumor suppressor in many cell types. Necessary but not sufficient for p53/TP53- mediated caspase activation and apoptosis. Has a role in cell trafficking, notably of the Schwann cell, and is necessary for the maintenance and development of the peripheral nerve myelin sheath. Required for vesicular recycling of CDH1 and TF. May also function in lipid trafficking. Protects cells from spindle disruption damage. Functions in p53/TP53-dependent mitotic spindle checkpoint. Regulates microtubule dynamics and maintains euploidy. {ECO:0000269|PubMed:15247272, ECO:0000269|PubMed:15377670, ECO:0000269|PubMed:17786215, ECO:0000269|PubMed:9766676}.;
- Disease
- DISEASE: Charcot-Marie-Tooth disease 4D (CMT4D) [MIM:601455]: A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot- Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. {ECO:0000269|PubMed:10831399}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Androgen Receptor Network in Prostate Cancer;TP53 Regulates Transcription of Cell Death Genes;VEGFA-VEGFR2 Signaling Pathway;Gene expression (Transcription);Generic Transcription Pathway;TP53 Regulates Transcription of Cell Death Genes;RNA Polymerase II Transcription;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;Transcriptional Regulation by TP53;Direct p53 effectors;Validated targets of C-MYC transcriptional repression;HIF-1-alpha transcription factor network
(Consensus)
Recessive Scores
- pRec
- 0.381
Intolerance Scores
- loftool
- 0.732
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.71
Haploinsufficiency Scores
- pHI
- 0.366
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.508
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ndrg1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); muscle phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- ndrg1b
- Affected structure
- thymus
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- signal transduction;negative regulation of cell population proliferation;response to metal ion;DNA damage response, signal transduction by p53 class mediator;peripheral nervous system myelin maintenance;regulation of apoptotic process;mast cell activation;cellular response to hypoxia;postsynapse organization
- Cellular component
- nucleus;cytoplasm;centrosome;cytosol;microtubule;plasma membrane;cell-cell adherens junction;microtubule cytoskeleton;myelin sheath;perinuclear region of cytoplasm;recycling endosome membrane;extracellular exosome;glutamatergic synapse
- Molecular function
- protein binding;microtubule binding;Rab GTPase binding;gamma-tubulin binding;cadherin binding